全文获取类型
收费全文 | 1110篇 |
免费 | 84篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 34篇 |
妇产科学 | 12篇 |
基础医学 | 130篇 |
口腔科学 | 6篇 |
临床医学 | 87篇 |
内科学 | 204篇 |
皮肤病学 | 60篇 |
神经病学 | 152篇 |
特种医学 | 116篇 |
外科学 | 136篇 |
综合类 | 32篇 |
预防医学 | 50篇 |
眼科学 | 4篇 |
药学 | 129篇 |
1篇 | |
肿瘤学 | 56篇 |
出版年
2021年 | 11篇 |
2020年 | 7篇 |
2019年 | 20篇 |
2018年 | 21篇 |
2017年 | 16篇 |
2016年 | 12篇 |
2015年 | 18篇 |
2014年 | 15篇 |
2013年 | 26篇 |
2012年 | 29篇 |
2011年 | 35篇 |
2010年 | 26篇 |
2009年 | 33篇 |
2008年 | 42篇 |
2007年 | 44篇 |
2006年 | 39篇 |
2005年 | 40篇 |
2004年 | 27篇 |
2003年 | 50篇 |
2002年 | 40篇 |
2001年 | 38篇 |
2000年 | 51篇 |
1999年 | 29篇 |
1998年 | 23篇 |
1997年 | 21篇 |
1996年 | 13篇 |
1995年 | 12篇 |
1994年 | 13篇 |
1993年 | 20篇 |
1992年 | 20篇 |
1991年 | 37篇 |
1990年 | 24篇 |
1989年 | 26篇 |
1988年 | 22篇 |
1987年 | 31篇 |
1986年 | 25篇 |
1985年 | 16篇 |
1984年 | 18篇 |
1983年 | 18篇 |
1982年 | 9篇 |
1981年 | 13篇 |
1980年 | 14篇 |
1979年 | 21篇 |
1978年 | 11篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1974年 | 15篇 |
1973年 | 11篇 |
1969年 | 6篇 |
排序方式: 共有1212条查询结果,搜索用时 156 毫秒
101.
Elizabeth D. Blume Christina VanderPluym Angela Lorts J. Timothy Baldwin Joseph W. Rossano David L.S. Morales Ryan S. Cantor Marissa A. Miller James D. St. Louis Devin Koehl David L. Sutcliffe Pirooz Eghtesady James K. Kirklin David N. Rosenthal 《The Journal of heart and lung transplantation》2018,37(1):38-45
102.
In vitro and in vivo activity of murine lymphokine-activated killer cells after cryopreservation 总被引:1,自引:0,他引:1
The in vitro and in vivo effects of cryopreservation on the cytotoxic activity of murine lymphokine-activated killer (LAK) cells were studied. LAK cells were generated by incubation of spleen lymphocytes of BALB/c mice for 3 days with recombinant interleukin-2 (rIL-2) and subsequent cryopreservation. Cytotoxicity was determined in a 51Cr release assay. After thawing, cytotoxic activity was reduced (40.4% 51Cr release at an effector:target cell ratio of 40:1 as compared to 68.5% 51Cr release before freezing) and could be restored to precryopreserved levels by reincubation with rIL-2 for 2 days after thawing (78.8% 51Cr release). These cells were then tested in BALB/c mice injected with RAW 112 cells, a pre-B-cell lymphoma line. The results demonstrate that the survival rate of mice injected with cryopreserved and restimulated LAK cells (50% survival greater than 180 days after injection) did not differ significantly from that of mice injected with fresh unfrozen LAK cells (60% survival greater than 120 days, 50% survival greater than 180 days). Cryopreserved LAK cells have potential use in adoptive immunotherapy. 相似文献
103.
The influence of carbohydrate gelling agents on rat intestinal transport of monosaccharides and neutral amino acids in vitro 总被引:1,自引:0,他引:1
B Elsenhans U Süfke R Blume W F Caspary 《Clinical science (London, England : 1979)》1980,59(5):373-380
1. In the present investigation with rings of everted rat small intestine, carbohydrate gelling agents (plant polysaccharides) such as guaran, pectin, tragacanth, carubin and carrageenan were employed to study their direct effect on intestinal absorption of alpha-methyl-D-glucoside, D-galactose, L-leucine and L-phenylalanine. 2. Inhibition was found to correlate with the viscosity of the incubation medium, a function only of the polysaccharide concentration, and was independent of other properties of the carbohydrate gelling agents. 3. Reversal of this inhibition was achieved either by washing the tissue free of polysaccharide or by raising tissue agitation. 4. Uptake kinetics in polysaccharide-containing solutions revealed a marked increase of the apparent Michaelis constant although the maximal transport capacity remained essentially unaltered. 5. Since there was no binding of the substrate by the polysaccharides under experimental conditions as judged by a membrane filtration technique, it is concluded that carbohydrate gelling agents may impair intestinal absorption by means of an increased unstirred layer resistance. 相似文献
104.
105.
Henning Blume Erich Brendel Margarete Brudny-Klöppel Sylvia Grebe Berthold Lausecker Gabriele Rohde Christoph Siethoff 《European journal of pharmaceutical sciences》2011,42(3):300-305
This is a summary report of the workshop on the EMA Draft Guideline on Validation of Bioanalytical Methods held April 15–16th 2010 in Brussels (Belgium) and jointly organised by the European Bioanalysis Forum (EBF) and the European Federation for Pharmaceutical Sciences (EUFEPS). Aim of the workshop was to discuss the current scientific knowledge in the area of bioanalysis, the regulatory requirements with special focus on the new Draft Guideline and their subsequent implementation to the work in bioanalytical laboratories. Comments on the Draft Guideline were presented and discussed with representatives from regulatory authorities in Europe. The workshop started with discussions on the scope of the Guideline and the need for implementation of GLP. A special focus was set on method validation of chromatographic procedures and subsequent study sample analysis. In addition, requirements for ligand-binding assays were briefly addressed. Intention of this Conference Report is to summarise important aspects of the discussions in order to draw certain conclusions, and to identify points which remain open and may require clarification at a later stage. 相似文献
106.
Chen ML Shah VP Crommelin DJ Shargel L Bashaw D Bhatti M Blume H Dressman J Ducharme M Fackler P Hyslop T Lutter L Morais J Ormsby E Thomas S Tsang YC Velagapudi R Yu LX 《European journal of pharmaceutical sciences》2011,44(4):506-513
Regulatory approaches for evaluating therapeutic equivalence of multisource (or generic) drug products vary among different countries and/or regions. Harmonization of these approaches may decrease the number of in vivo bioequivalence studies and avoid unnecessary drug exposure to humans. Global harmonization for regulatory requirements may be promoted by a better understanding of factors underlying product performance and expectations from different regulatory authorities. This workshop provided an opportunity for pharmaceutical scientists from academia, industry and regulatory agencies to have open discussions on current regulatory issues and industry practices, facilitating harmonization of regulatory approaches for establishing therapeutic equivalence and interchangeability of multisource drug products. 相似文献
107.
108.
Stretch is applied to skin under normal physiological conditions, for example pregnancy, or artificially using soft tissue expanders. Because cells are known to orient in response to the application of mechanical forces, the current studies were carried out to assess the effects of stretch on dermal fibroblast orientation and cell signalling. Dermal fibroblasts were seeded onto collagen‐coated flexible membranes and grown to 70–80% confluence. Membranes were then deformed at 10 cycles per minute by the application of 135 mmHg subatmospheric pressure. This corresponded to strain levels of 0–24% from the centre to extremity of the flexible membrane. We show that a minimum of 15% cell stretch is required to significantly stimulate the fibroblast orientation response. focal adhesion kinase (FAK), p38 and Rho were activated in fibroblasts exposed to cyclic stretch and incubation of cells with anti‐integrin β1 before the application of stretch abrogated fibroblast orientation, as well as FAK, p38 and Rho activation. Fibroblast orientation in response to cyclic stretch is mediated at least in part by integrin β1 through phosphorylation of FAK, p38 and activation of Rho. 相似文献
109.
110.
Sands MF Ohtake PJ Mahajan SD Takyar SS Aalinkeel R Fang YV Blume JW Mullan BA Sykes DE Lachina S Knight PR Schwartz SA 《Clinical immunology (Orlando, Fla.)》2009,130(2):186-198
Matrix metalloproteinases (MMPs) modulate development, inflammation, and repair in lungs. Tissue inhibitors of MMPs (TIMPs) interact with MMPs, controlling the intensity and nature of the response to injury. Absence of MMP-9, -2, and -8 activities is associated with altered lung inflammation during allergic sensitization. To test the hypothesis that the absence of TIMP-1 enhances allergic lung inflammation, airway hyperreactivity (AHR), and lung remodeling in asthma, we studied TIMP-1 null (TIMP-1 KO) mice and their WT controls using an ovalbumin (OVA) asthma model. TIMP-1 KO mice, compared to WT controls, developed an asthma phenotype characterized by AHR, pronounced cellular lung infiltrates, greater reduction in lung compliance, enhanced Th2 cytokine mRNA and protein expression, and altered collagen lung content associated with enhanced MMP-9 activity. Our findings support the hypothesis that TIMP-1 plays a protective role by preventing AHR and modulating inflammation, remodeling, and cytokine expression in an animal model of asthma. 相似文献